Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03501381
Title High Dose IL 2 and Entinostat in RCC
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Roberto Pili
Indications

renal cell carcinoma

Therapies

Entinostat + Interleukin-12

Interleukin-12

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Univeristy of Southern California Los Angeles California 90033 United States Details
Rush University Medical Center Chicago Illinois 60612 United States Details
Indiana Univeristy Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202 United States Details
Hematology Oncology Clinic, LLC Baton Rouge Louisiana 70809 United States Details
Nebraska Methodist Hospital Omaha Nebraska 68114 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field